International Urology and Nephrology (2018) 50:1069–1070 https://doi.org/10.1007/s11255-018-1879-9 RESPONSE - UROLOGY LE T TER Re: Concordance of renal stone culture: PMUC, RPUC, RSC and post- PCNL sepsis—a non-randomized prospective observation cohort study 1 1 1 Fernando Marchant · Andres Vega‑Avalos · Alejandro Mercado Received: 16 April 2018 / Accepted: 18 April 2018 / Published online: 5 May 2018 © Springer Science+Business Media B.V., part of Springer Nature 2018 Dear Editor, tory response syndrome (SIRS). Among this group, only four of them had positive RPUC or RSC. Three out of We would like to thank to Dr. Bozkurt and colleagues for the four isolated bacterial strains (75%) were resistant their valuable comments and very interesting questions. to ceftriaxone (Patient 1, 2 and 6) and in them we had After going through our data and discussing, we want to to change the antibiotic regimen. Lojanapiwat et al.  clarify: did not state that it was necessary to change the cef- triaxone based prophylaxis, but to use amikacin, ampi- 1. In our study , 28 (23%) patients had positive cultures cilin, vancomycin or carbapenemics following PCNL from either renal pelvis (RPUC) and/or renal stone sam- if an infectious complication develops, and we totally ples (RSC). Of the isolated bacterial
International Urology and Nephrology – Springer Journals
Published: May 5, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera